Tag: bacterial vaginosis market size

  • Bacterial Vaginosis Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

    Bacterial Vaginosis Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

    Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

    What Are the Projected Market Size and Growth Rates for the Bacterial Vaginosis Market From 2025 To 2029?

    The bacterial vaginosis market has experienced robust growth in the past years with its size projected to expand from $3.03 billion in 2024 to $3.32 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.7%. Various factors have contributed to this growth during the historic period, including the growing adoption of point-of-care diagnostics, the expansion of e-commerce, an increase in risky sexual behaviors, a rise in STI vaccination, and improved healthcare access.

    The bacterial vaginosis market is set to experience significant expansion in the upcoming years, reaching a value of $4.75 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. This projected growth can be attributed to factors such as the heightened prevalence of bacterial vaginosis, the growing need for functional foods, an uptick in sexually transmitted infections, increased prevalence of women’s health issues, and a surge in menopause awareness. Key emerging trends in the forecast period include leveraging artificial intelligence in diagnostics, the uptake of probiotics, progress in at-home STI testing, and the use of sustainable materials in women’s health devices.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

    What Are the Core Market Drivers Propelling Growth in the Bacterial Vaginosis Industry?

    The bacterial vaginosis market is anticipated to grow due to the surging number of sexually transmitted infections (STIs). STIs essentially are infections spread primarily through sexual activities and can be induced by bacteria, parasites, or viruses. The growth in the incidence of STIs is associated with factors such as having multiple partners, engaging in unprotected sex, antibiotic resistance, and lack of awareness. Bacterial vaginosis intensifies susceptibility to STIs by mediating the imbalance of vaginal bacteria, further easing the transmission of infections like HIV and chlamydia. For example, in March 2024, as per the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, there was a substantial growth in reported cases in 2022 compared to the prior year. This was seen with gonorrhea increasing by 48%, syphilis by 34%, and chlamydia enhanced by 16%. Consequently, the rising prevalence of STIs is propelling the bacterial vaginosis market.

    How Is the Bacterial Vaginosis Market Segmented?

    The bacterial vaginosis market covered in this report is segmented –

    1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types

    2) By Product: Below 15 Years, Between 15-45, Other Products

    3) By Application: Antibiotics, Other Applications

    4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

    Subsegments:

    1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays

    2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing

    3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

    Which Regions Are Driving the Next Phase of the Bacterial Vaginosis Market Growth?

    North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Key Market Trends and Innovations Are Shaping the Future of the Bacterial Vaginosis Industry?

    Leading players in the bacterial vaginosis market are concentrating on developing innovative tools like multiplexed polymerase chain reaction (PCR) tests to escalate the pace of diagnosis and treatment. Multi-PCR tests are used to simultaneously expand and detect numerous target DNA or RNA sequences within a single PCR experiment. For example, in November 2022, the biotechnology research firm Cepheid, based in the US, released the Xpert Xpress Multiplex Vaginal Panel (MVP). This panel can deliver quick results in less than an hour and can identify three types of vaginal infections—bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) using just one sample. It is designed to accommodate both medical professional and self-collected swabs, utilizing automated real-time PCR technology to increase diagnostic precision and advance treatment results for women. Its adaptability makes it suitable for diverse clinical environments while ensuring accurate and fast detection of vaginal infections.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

    How Is the Bacterial Vaginosis Market Defined and What Are Its Core Parameters?

    Bacterial vaginosis (BV) is a common vaginal infection caused by an imbalance of naturally occurring bacteria, leading to a decrease in lactobacilli and an overgrowth of anaerobic bacteria. It is characterized by symptoms such as a fishy odor, thin grayish-white discharge, and vaginal discomfort, though some cases may be asymptomatic.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21110

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Bacterial Vaginosis Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

    Bacterial Vaginosis Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Industry-Specific Factors Are Fueling the Growth of theBacterial Vaginosis Market?

    The increasing incidence of sexually transmitted infections (STIs) is anticipated to contribute to the growth of the bacterial vaginosis market in the future. STIs are infections primarily spread through sexual contact, caused by bacteria, viruses, or parasites. The rising incidence of STIs is linked to factors such as unprotected sex, multiple sexual partners, lack of awareness, and antibiotic resistance. Bacterial vaginosis increases susceptibility to STIs by disturbing the vaginal bacterial balance, making it easier for infections like HIV and chlamydia to take hold. For instance, in March 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported a significant increase in reported STI cases in 2022 compared to the previous year, with gonorrhea rising by 48%, syphilis by 34%, and chlamydia by 16%. Therefore, the increasing incidence of STIs is propelling the growth of the bacterial vaginosis market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

    What is the Predicted Annual Growth Rate of theBacterial Vaginosis Market Impact Industry Trends by 2034?

    The bacterial vaginosis market has expanded strongly. It is forecasted to grow from $3.03 billion in 2024 to $3.32 billion in 2025, achieving a CAGR of 9.7%. Key drivers of past growth include greater adoption of point-of-care diagnostics, the rise of e-commerce, changes in sexual behaviors, increased STI vaccinations, and improved healthcare access.

    The bacterial vaginosis market size is projected to witness steady expansion, growing to $4.75 billion by 2029 at a CAGR of 9.4%. Growth will be supported by rising cases of bacterial vaginosis, increasing demand for functional foods, a higher incidence of sexually transmitted infections (STIs), a growing prevalence of women’s health conditions, and greater awareness of menopause. Notable trends will include AI-driven diagnostics, wider adoption of probiotics, progress in home-based STI testing, and the use of sustainable materials in women’s health devices.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21110

    What Key Market Trends and Innovations Are Shaping the Future of theBacterial Vaginosis Industry?

    In the bacterial vaginosis market, companies are working on multiplexed PCR tests to enhance diagnostic speed and treatment accuracy. For instance, in November 2022, Cepheid, a U.S.-based biotechnology company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This test detects three vaginal infections—bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis—within 60 minutes from a single sample, improving diagnostic accuracy and clinical efficiency.

    Which Companies Are Leading the Charge in Expanding theBacterial Vaginosis Market Growth?

    Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

    How is the Global Bacterial Vaginosis Market Segemented?

    The bacterial vaginosis market covered in this report is segmented –

    1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types

    2) By Product: Below 15 Years, Between 15-45, Other Products

    3) By Application: Antibiotics, Other Applications

    4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

    Subsegments:

    1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays

    2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing

    3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

    Which Geographics are Influencing the Growth of the Bacterial Vaginosis Market?

    North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2025, By The Business Research Company:

    Anemia and Other Blood Disorder Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

    Blood Cancer Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

    Proton Pump Inhibitors Global Market Report 2025

    https://thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s Driving Growth in the Bacterial Vaginosis Market? Insights into Key Trends and Opportunities

    What’s Driving Growth in the Bacterial Vaginosis Market? Insights into Key Trends and Opportunities

    Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    How has the bacterial vaginosis market grown in recent years?

    In recent times, the market size for bacterial vaginosis has witnessed substantial growth. It is projected to expand from $3.03 billion in 2024 to $3.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.7%. This growth during the historical period is a result of factors like the rising adoption of point-of-care diagnostics, the surge in e-commerce, an increase in precarious sexual behaviors, an uptick in STI vaccinations, and widened access to healthcare.

    How is the bacterial vaginosis market size expected to evolve during the forecast period?

    The market size for bacterial vaginosis is anticipated to experience robust expansion in the upcoming years, reaching $4.75 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. The escalation during the forecast period can be associated with the growing occurrence of bacterial vaginosis, the surge in demand for functional foods, the increasing incidence of sexually transmitted infections (STIs), escalating women’s health conditions prevalence, and increased menopause awareness. Foreseen trends for the forecast period encompass the utilization of artificial intelligence (AI) in diagnoses, the adoption of probiotics, advances in STI testing at home, and the use of sustainable materials in women’s health devices.

    Get your bacterial vaginosis market report here!

    https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

    Which key drivers are propelling the bacterial vaginosis market’s growth?

    The escalating prevalence of sexually transmitted infections (STIs) is poised to propel the expansion of the bacterial vaginosis market. STIs encompass infections predominantly passed on through sexual interaction, caused by bacteria, viruses or parasites. The heightened prevalence of these infections is attributable to unprotected sex, a multitude of partners, lack of cognizance, and antibiotic resistance. The prevalence of bacterial vaginosis, which disrupts the vaginal bacterial harmony, augments the likelihood of infections like HIV and chlamydia. In an instance, the European Centre for Disease Prevention and Control (ECDC), seated in Sweden, reported a significant leap in reported cases in 2022 compared to the prior year, with gonorrhea swelling by 48%, syphilis by 34%, and chlamydia by 16% as of March 2024. As such, the surging prevalence of STIs is underpinning the progression of the bacterial vaginosis market.

    What are the market segments in the bacterial vaginosis industry?

    The bacterial vaginosis market covered in this report is segmented –

    1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types

    2) By Product: Below 15 Years, Between 15-45, Other Products

    3) By Application: Antibiotics, Other Applications

    4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

    Subsegments:

    1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays

    2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing

    3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

    Which leading companies are shaping the growth of the bacterial vaginosis market?

    Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

    What key trends are currently impacting the bacterial vaginosis market’s development?

    The bacterial vaginosis market is experiencing a boost as dominant companies prioritize developing innovative solutions like multiplexed polymerase chain reaction (PCR) tests, intending to hasten diagnosis and treatment procedures. Multiplexed PCR tests have the ability to simultaneously amplify and detect numerous target DNA or RNA sequences within a singular PCR experiment. For example, Cepheid, a biotechnology research firm based in the U.S., launched the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This panel can provide results within an hour and efficiently detects three types of vaginal infections – bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) – from just a single sample. The system is adaptable to both clinician-acquired and self-acquired swabs, maximizing the diagnostic precision and advancing treatment outcomes for women using automated real-time PCR technology. Its applicability in various clinical environments ensures effective and accurate identification of vaginal infections.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21110

    Which geographic areas are influencing the growth of the bacterial vaginosis market?

    North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Anemia and Other Blood Disorder Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

    Blood Cancer Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

    Proton Pump Inhibitors Global Market Report 2025

    https://thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Bacterial Vaginosis Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities

    Bacterial Vaginosis Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Growth Rate of the Bacterial Vaginosis Market Shape Industry Trends by 2034?

    In the past few years, the bacterial vaginosis market has seen considerable growth. Projected growth indicates a rise from $3.03 billion in 2024 to $3.32 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. Factors contributing to the expansion during the historic period include increased use of point-of-care diagnostics, the proliferation of e-commerce, a surge in risky sexual practices, an upturn in STI vaccination, and better healthcare accessibility.

    In the coming years, substantial growth is anticipated in the bacterial vaginosis market, predicted to reach a value of $4.75 billion in 2029 with a 9.4% CAGR. Factors driving this growth within the forecast timeframe include the heightened occurrence of bacterial vaginosis, a growing market for health-promoting food products, an increased number of sexually transmitted infections, heightened prevalence of health issues in women, and a surge in menopause awareness. The forecast phase will also see some significant trends, such as the use of artificial intelligence in diagnostic procedures, the adoption of probiotics, progress in testing for STIs at home, and the incorporation of sustainable materials in devices related to women’s health.

    How Are the key drivers Contributing to the Expansion of the Bacterial Vaginosis Market?

    The growth of the bacterial vaginosis market is projected to be propelled by the escalating prevalence of sexually transmitted infections (STIs). STIs are primarily passed through sexual intercourse and can be caused by bacteria, viruses, or parasites. The surge in STI occurrences is attributed to unprotected sex, having several partners, a lack of knowledge about these diseases, and antibiotic resistance. Bacterial vaginosis enhances the chances of contracting STIs as it disrupts the bacterial equilibrium in the vagina, which promotes infections like HIV and chlamydia to prosper. For example, in March 2024, the European Centre for Disease Prevention and Control (ECDC), a government entity based in Sweden, reported a substantial surge in cases in 2022 compared to the prior year, with a 48% increase in gonorrhea, a 34% increase in syphilis, and a 16% increase in chlamydia. Consequently, the rise in sexually transmitted infections is fueling the expansion of the bacterial vaginosis market.

    Explore Comprehensive Insights Into The Global Bacterial Vaginosis Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

    Who Are the Key Market Players Influencing the Growth of the Bacterial Vaginosis Industry?

    Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

    What Key Market Trends Are Shaping the Future of the Bacterial Vaginosis Industry?

    Leading firms in the bacterial vaginosis industry are concentrating their efforts on creating inventive solutions like multiplexed polymerase chain reaction (PCR) tests, aiming to improve the speed and efficacy of diagnosis and treatment. A multiplexed PCR test is a specific kind of PCR examination that enables the simultaneous amplification and identification of multiple DNA or RNA targets within a single PCR analysis. In November 2022, for example, the American biotech research firm Cepheid launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This panel delivers swift results in less than 60 minutes, recognizing three distinct vaginal infections—bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) from just one specimen. The panel aids in the collection of swabs by clinicians and patients themselves, utilizing automated real-time PCR technology to heighten the precision of diagnostics and enhance treatment results for women. Its adaptability enables its use across various clinical scenarios, facilitating accurate and timely diagnosis of vaginal infections.

    Secure Your Global Bacterial Vaginosis Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

    What Are the Main Segments of the Bacterial Vaginosis Market, and How Are They Evolving?

    The bacterial vaginosis market covered in this report is segmented –

    1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types

    2) By Product: Below 15 Years, Between 15-45, Other Products

    3) By Application: Antibiotics, Other Applications

    4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

    Subsegments:

    1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays

    2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing

    3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)

    Which Regions Are Emerging as Leaders in the Bacterial Vaginosis Market?

    North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Defining Features of the Bacterial Vaginosis Market?

    Bacterial vaginosis (BV) is a common vaginal infection caused by an imbalance of naturally occurring bacteria, leading to a decrease in lactobacilli and an overgrowth of anaerobic bacteria. It is characterized by symptoms such as a fishy odor, thin grayish-white discharge, and vaginal discomfort, though some cases may be asymptomatic.

    Browse Through More Similar Reports By The Business Research Company:

    Anemia and Other Blood Disorder Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

    Blood Cancer Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

    Proton Pump Inhibitors Global Market Report 2025

    https://thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: